Arnold & Porter was among the firms recognized with the “Private Equity Deal of the Year” honor at the 2025 IFLR Americas Awards for its role in advising CVC Capital Partners on its $925 million acquisition of the Therakos business from pharmaceuticals company Mallinckrodt Pharmaceuticals plc. The 2025 IFLR Americas Awards aim to highlight “the most innovative cross-border deals closed in the region in 2024.” Arnold & Porter’s internationally recognized life sciences and intellectual property teams provide comprehensive support to clients, enabling them to successfully navigate and complete complex transactions.
The Arnold & Porter team advising CVC Capital Partners included partners Eva Temkin, Liz Lindquist, Jackie Mulryne, Beatriz San Martin, and David Marsh, counsel Monique Nolan, senior associates Eleri Abreo, Claire Dennis, Alyssa Lattner, and Alyson Nickols, and associates Dorothy Chen, Zahrah Kazim, and Eftychia Sideri.